CN105348548B - A kind of hydrogel microsphere based on glucan and preparation method thereof - Google Patents
A kind of hydrogel microsphere based on glucan and preparation method thereof Download PDFInfo
- Publication number
- CN105348548B CN105348548B CN201510704378.4A CN201510704378A CN105348548B CN 105348548 B CN105348548 B CN 105348548B CN 201510704378 A CN201510704378 A CN 201510704378A CN 105348548 B CN105348548 B CN 105348548B
- Authority
- CN
- China
- Prior art keywords
- dextran
- hydrogel microspheres
- deionized water
- preparation
- precipitate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000004005 microsphere Substances 0.000 title claims abstract description 128
- 239000000017 hydrogel Substances 0.000 title claims abstract description 114
- 238000002360 preparation method Methods 0.000 title claims abstract description 43
- 229920001503 Glucan Polymers 0.000 title claims abstract description 4
- 229920002307 Dextran Polymers 0.000 claims abstract description 181
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 86
- 239000008367 deionised water Substances 0.000 claims abstract description 69
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 69
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims abstract description 39
- 239000002244 precipitate Substances 0.000 claims abstract description 39
- 150000001412 amines Chemical class 0.000 claims abstract description 34
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 34
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 33
- 238000003756 stirring Methods 0.000 claims abstract description 33
- 239000000243 solution Substances 0.000 claims abstract description 31
- 239000007787 solid Substances 0.000 claims abstract description 25
- 238000005119 centrifugation Methods 0.000 claims abstract description 22
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims abstract description 22
- 239000011259 mixed solution Substances 0.000 claims abstract description 21
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 21
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 21
- 239000004530 micro-emulsion Substances 0.000 claims abstract description 15
- 239000007864 aqueous solution Substances 0.000 claims description 32
- 238000000502 dialysis Methods 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 18
- 125000003277 amino group Chemical group 0.000 claims description 16
- 125000003172 aldehyde group Chemical group 0.000 claims description 12
- 238000003860 storage Methods 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000004945 emulsification Methods 0.000 claims description 10
- 239000005457 ice water Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 229920002873 Polyethylenimine Polymers 0.000 claims description 9
- 239000004627 regenerated cellulose Substances 0.000 claims description 8
- 238000010907 mechanical stirring Methods 0.000 claims description 7
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 3
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 229940051841 polyoxyethylene ether Drugs 0.000 claims description 2
- 229920000056 polyoxyethylene ether Polymers 0.000 claims description 2
- -1 polyoxyethylene pentanonylphenyl ether Polymers 0.000 claims description 2
- 239000001593 sorbitan monooleate Substances 0.000 claims description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 claims description 2
- 229940035049 sorbitan monooleate Drugs 0.000 claims description 2
- 229950004959 sorbitan oleate Drugs 0.000 claims description 2
- 239000002245 particle Substances 0.000 abstract description 9
- 239000002861 polymer material Substances 0.000 abstract description 7
- 239000012429 reaction media Substances 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 13
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 12
- 229920000053 polysorbate 80 Polymers 0.000 description 12
- 229920005654 Sephadex Polymers 0.000 description 7
- 239000002105 nanoparticle Substances 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 230000022244 formylation Effects 0.000 description 6
- 238000006170 formylation reaction Methods 0.000 description 6
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 125000003916 ethylene diamine group Chemical group 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 150000004804 polysaccharides Chemical class 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000001878 scanning electron micrograph Methods 0.000 description 4
- 238000004626 scanning electron microscopy Methods 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 238000013329 compounding Methods 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 239000011859 microparticle Substances 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- 238000010382 chemical cross-linking Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- CBMPTFJVXNIWHP-UHFFFAOYSA-L disodium;hydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical class [Na+].[Na+].OP([O-])([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O CBMPTFJVXNIWHP-UHFFFAOYSA-L 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000000593 microemulsion method Methods 0.000 description 1
- 238000012703 microemulsion polymerization Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003058 plasma substitute Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/12—Chemical modification
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/02—Dextran; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及一种基于葡聚糖的水凝胶微球及其制备方法,属于生物医用高分子材料技术领域。首先将葡聚糖在室温下溶解在水中,加入高碘酸钠获得混合液,搅拌后透析、冷冻干燥得到部分醛基化葡聚糖固体;将得到的部分醛基化葡聚糖溶于去离子水中并加入溶解了乳化剂的环己烷溶液,加入胺类交联剂搅拌,最后通过离心收集沉淀物,清洗后得到化学交联型葡聚糖水凝胶微球;向得到分散于去离子水中的化学交联型葡聚糖水凝胶微球中加入硼氢化钠,在室温下搅拌24h,最后通过离心收集沉淀物,经去离子水清洗后得到还原后的葡聚糖水凝胶微球。本发明提出以“油包水”反相微乳液体系为反应介质,制备粒径大小可控且具有良好稳定性的葡聚糖基水凝胶微球。
The invention relates to a dextran-based hydrogel microsphere and a preparation method thereof, belonging to the technical field of biomedical polymer materials. First, dissolve the dextran in water at room temperature, add sodium periodate to obtain a mixed solution, dialyze after stirring, and freeze-dry to obtain a part of the aldylated glucan solid; Add the cyclohexane solution dissolved in the emulsifier in deionized water, add the amine cross-linking agent and stir, and finally collect the precipitate by centrifugation, and obtain the chemical cross-linked dextran hydrogel microspheres after washing; Sodium borohydride was added to the chemically cross-linked dextran hydrogel microspheres in water, stirred at room temperature for 24 hours, and finally the precipitate was collected by centrifugation, washed with deionized water to obtain reduced dextran hydrogel microspheres. The invention proposes to use the "water-in-oil" inverse microemulsion system as a reaction medium to prepare dextran-based hydrogel microspheres with controllable particle size and good stability.
Description
技术领域technical field
本发明涉及一种基于葡聚糖的水凝胶微球及其制备方法,属于生物医用高分子材料技术领域。The invention relates to a dextran-based hydrogel microsphere and a preparation method thereof, belonging to the technical field of biomedical polymer materials.
背景技术Background technique
水凝胶是一种聚合物通过物理或化学交联形成的三维网络结构,在水溶液中能够溶胀并保持大量水分而又不能溶解,亲水的小分子可以在水凝胶中扩散。水凝胶微球同时具备了水凝胶和微/纳米粒子双方面的特性。由于其具有较小的尺寸、较大的比表面积等,同时还具有水凝胶的尺寸稳定性和高溶液吸收性能,因此,水凝胶微/纳米粒子作为生物医用材料在组织工程、药物传递等领域具有巨大的应用潜力和广阔的应用前景(Thedevelopment of microgels/nanogels for drug delivery applications, Progress inPolymer Science, 2008. 33: 448-477; Microgels in Drug Delivery, in MicrogelSuspensions, 2011, Wiley-VCH Verlag GmbH & Co. KGaA. 375-405)。Hydrogel is a three-dimensional network structure formed by physical or chemical cross-linking of polymers, which can swell in aqueous solution and retain a large amount of water without dissolving, and hydrophilic small molecules can diffuse in the hydrogel. Hydrogel microspheres have both properties of hydrogel and micro/nanoparticles. Due to its small size, large specific surface area, etc., as well as the dimensional stability and high solution absorption performance of hydrogels, hydrogel micro/nanoparticles are used as biomedical materials in tissue engineering, drug delivery, etc. and other fields have great application potential and broad application prospects (The development of microgels/nanogels for drug delivery applications, Progress in Polymer Science, 2008. 33: 448-477; Microgels in Drug Delivery, in Microgel Suspensions, 2011, Wiley-VCH Verlag GmbH & Co. KGaA. 375-405).
基于天然高分子材料的水凝胶具有优良的生物安全性,作为生物材料备受关注。多糖是一类具有良好生物相容性的天然聚合物,以天然多糖高分子材料构建的水凝胶具有良好的生物相容性和生物降解性,作为生物医用高分子材料广泛应用于组织工程、基因载体和药物载体,目前关于多糖凝胶微球的研究主要围绕壳聚糖及海藻酸开展。葡聚糖(dextran),又称右旋糖酐,是一种分子结构上带有大量游离羟基的细菌性多糖,具有良好的水溶性和生物安全性。自十九世纪四十年代开始,葡聚糖作为一种临时性血浆替代品广泛应用于临床,因此基于葡聚糖的水凝胶微球作为药物载体材料具有广泛的临床应用前景。Hydrogels based on natural polymer materials have excellent biological safety and have attracted much attention as biomaterials. Polysaccharides are a class of natural polymers with good biocompatibility. Hydrogels constructed of natural polysaccharide polymer materials have good biocompatibility and biodegradability. As biomedical polymer materials, they are widely used in tissue engineering, Gene carrier and drug carrier, the current research on polysaccharide gel microspheres mainly revolves around chitosan and alginic acid. Dextran, also known as dextran, is a bacterial polysaccharide with a large number of free hydroxyl groups in its molecular structure, which has good water solubility and biological safety. Since the 1940s, dextran has been widely used clinically as a temporary plasma substitute, so dextran-based hydrogel microspheres have broad clinical application prospects as drug carrier materials.
目前,以聚合物为材料基础的水凝胶微球的制备方法一般分为四大类(Nanogelsas Pharmaceutical Carriers: Finite Networks of Infinite Capabilities.Angewandte Chemie International Edition, 2009. 48: 5418-5429):(1)利用高分子间的氢键、亲疏水力、静电作用力等物理作用力“自组装”形成水凝胶微球;(2)通过引发微乳液体系中的单体聚合制备凝胶微球,聚合过程可以在均相体系中进行,也可以在具有纳米尺寸的异相环境中进行;(3)通过化学交联,高分子间以共价键连接形成凝胶微球;(4)利用“平板印刷术”或“微流体”等纳米材料加工方法来制备水凝胶微球。其中,微乳液聚合法通常是将聚合单体加入到含有乳化剂而无引发剂的水相(油相)中,加至油相(水相)中剧烈搅拌形成小液滴,再加入引发剂或通过高能辐射在水相(油相)中引发单体聚合形成纳米粒子。而“油包水”的反相微乳液方法在制备水凝胶纳米颗粒方面具有反应条件温和、凝胶微球粒径容易控制等优点,因此是制备微/纳米粒子材料的一种常用方法(The Generationof Nanoparticles in Miniemulsions. Advanced Materials, 2001. 13: 765-768;Miniemulsion Polymerization and the Structure of Polymer and HybridNanoparticles. Angewandte Chemie International Edition, 2009. 48: 4488-4507),但目前关于该方法用于制备葡聚糖基水凝胶的文献报道较少,尚未提出适用的反应条件和表面活性剂体系。At present, the preparation methods of hydrogel microspheres based on polymer materials are generally divided into four categories (Nanogelsas Pharmaceutical Carriers: Finite Networks of Infinite Capabilities. Angewandte Chemie International Edition , 2009. 48: 5418-5429): (1 )Using physical forces such as hydrogen bonds between polymers, hydrophilic and hydrophobic forces, and electrostatic forces to "self-assemble" to form hydrogel microspheres; The process can be carried out in a homogeneous system or in a heterogeneous environment with a nanometer size; (3) Through chemical cross-linking, the polymers are connected by covalent bonds to form gel microspheres; (4) using "plate Nanomaterial processing methods such as "printing" or "microfluidics" are used to prepare hydrogel microspheres. Among them, the microemulsion polymerization method is usually to add the polymerized monomer to the water phase (oil phase) containing an emulsifier without an initiator, add it to the oil phase (water phase) and stir vigorously to form small droplets, and then add the initiator Or initiate polymerization of monomers in the water phase (oil phase) by high-energy radiation to form nanoparticles. The "water-in-oil" inverse microemulsion method has the advantages of mild reaction conditions and easy control of the particle size of gel microspheres in the preparation of hydrogel nanoparticles, so it is a common method for preparing micro/nanoparticle materials ( The Generation of Nanoparticles in Miniemulsions. Advanced Materials, 2001. 13: 765-768; Miniemulsion Polymerization and the Structure of Polymer and Hybrid Nanoparticles. Angewandte Chemie International Edition, 2009. 48: 4488-4507), but currently there is no information about this method for the preparation of grape There are few literature reports on polysaccharide-based hydrogels, and the applicable reaction conditions and surfactant systems have not been proposed yet.
发明内容Contents of the invention
针对上述现有技术存在的问题及不足,本发明提供一种基于葡聚糖的水凝胶微球及其制备方法。本发明提出以“油包水”反相微乳液体系为反应介质,通过调节构成反相微乳液的表面活性剂种类、含量、表面活性剂复配比例以及乳化方法等因素,制备粒径大小可控且具有良好稳定性的葡聚糖基水凝胶微球,本发明通过以下技术方案实现。Aiming at the problems and deficiencies in the above-mentioned prior art, the present invention provides a dextran-based hydrogel microsphere and a preparation method thereof. The present invention proposes to use the "water-in-oil" inverse microemulsion system as the reaction medium, and by adjusting factors such as the surfactant type, content, surfactant compounding ratio and emulsification method that constitute the inverse microemulsion, the particle size can be prepared Controlled and stable dextran-based hydrogel microspheres, the present invention is achieved through the following technical solutions.
一种基于葡聚糖的水凝胶微球,其结构式可表示如下:A kind of hydrogel microsphere based on dextran, its structural formula can be expressed as follows:
。 .
一种上述的基于葡聚糖的水凝胶微球的制备方法,其具体步骤包括如下:A kind of preparation method of above-mentioned dextran-based hydrogel microspheres, its concrete steps comprise as follows:
(1)醛基化葡聚糖的制备(1) Preparation of aldylated dextran
将葡聚糖在室温下按照固液比为10:100g/ml溶解在水中,然后置于冰水浴中按照糖单元/IO4 -摩尔比为2:1~1:1加入高碘酸钠获得混合液,将混合液在室温、避光条件下搅拌反应2~6h,获得的溶液用再生纤维素透析袋在去离子水中透析2~3天,透析过程中每3~5h换一次去离子水,透析完成后冷冻干燥得到醛基化程度为40~60%的部分醛基化葡聚糖固体(即每100个糖单元中有40~60个被氧化,具体醛基化程度通过盐酸羟胺滴定法进行测定);Dissolve dextran in water at room temperature according to the solid-to-liquid ratio of 10:100g/ml, then place it in an ice-water bath and add sodium periodate according to the sugar unit/IO 4 -molar ratio of 2:1~1:1 to obtain Mixed solution, the mixed solution was stirred and reacted at room temperature and protected from light for 2-6 hours, and the obtained solution was dialyzed in deionized water with a regenerated cellulose dialysis bag for 2-3 days, and the deionized water was changed every 3-5 hours during the dialysis process , freeze-dried after dialysis to obtain partially aldylated dextran solids with a degree of aldylation of 40-60% (that is, 40-60 of every 100 sugar units were oxidized, and the degree of aldylation was titrated by hydroxylamine hydrochloride method for determination);
(2)葡聚糖水凝胶微球的制备(2) Preparation of dextran hydrogel microspheres
将步骤(1)得到的部分醛基化葡聚糖固体溶于去离子水中得到浓度为100~200mg/mL的醛基化葡聚糖水溶液,在室温下,将醛基化葡聚糖水溶液加入溶解了乳化剂的环己烷溶液中,乳化形成反相微乳液,然后加入胺类交联剂搅拌10~12h,最后通过离心收集沉淀物,沉淀物经乙醇清洗后得到化学交联型葡聚糖水凝胶微球,分散于去离子水中保存;Dissolve the partially formylated dextran solid obtained in step (1) in deionized water to obtain an aqueous solution of formylated dextran with a concentration of 100-200 mg/mL, and add the aqueous solution of formylated dextran to the In the cyclohexane solution in which the emulsifier is dissolved, emulsify to form a reverse microemulsion, then add an amine cross-linking agent and stir for 10-12 hours, and finally collect the precipitate by centrifugation, and wash the precipitate with ethanol to obtain a chemically cross-linked glucan Sugar hydrogel microspheres, dispersed in deionized water for preservation;
(3)葡聚糖水凝胶微球的还原(3) Reduction of dextran hydrogel microspheres
向步骤(2)得到分散于去离子水中的化学交联型葡聚糖水凝胶微球中加入硼氢化钠,在室温下搅拌24h,最后通过离心收集沉淀物,沉淀物经去离子水清洗后得到还原后的葡聚糖水凝胶微球,分散于去离子水中保存。Add sodium borohydride to the chemically cross-linked dextran hydrogel microspheres dispersed in deionized water obtained in step (2), stir at room temperature for 24 hours, and finally collect the precipitate by centrifugation, and wash the precipitate with deionized water The reduced dextran hydrogel microspheres are obtained and dispersed in deionized water for storage.
所述步骤(1)中的葡聚糖为分子量10000g/mol~100000g/mol的葡聚糖中的任一种。The dextran in the step (1) is any one of dextran with a molecular weight of 10000g/mol~100000g/mol.
所述步骤(2)中醛基化葡聚糖水溶液与环己烷体积比为1:5~1:10。In the step (2), the volume ratio of the aqueous solution of aldylated dextran to cyclohexane is 1:5-1:10.
所述步骤(2)中的乳化剂为聚氧代乙烯(5)壬基苯基醚(CO-520)、失水山梨醇油酸酯(Span80)或Span80/失水山梨醇单油酸酯聚氧乙烯醚(Tween80)的复配剂(该复配剂中Tween80为Span80质量的5%~20%)中的任一种,乳化剂的加入量为环己烷质量的10~50%。The emulsifier in the step (2) is polyoxyethylene (5) nonylphenyl ether (CO-520), sorbitan oleate (Span80) or Span80/sorbitan monooleate Any one of the compounding agent of polyoxyethylene ether (Tween80) (Tween80 in the compounding agent is 5%~20% of the mass of Span80), the amount of emulsifier added is 10~50% of the mass of cyclohexane.
所述步骤(2)中乳化为机械搅拌乳化或者超声乳化。The emulsification in the step (2) is mechanical stirring emulsification or ultrasonic emulsification.
所述步骤(2)中的胺类交联剂为乙二胺、赖氨酸、精氨酸中的任一种带有两个氨基的化合物,加入量为按照部分醛基化葡聚糖中醛基与胺类交联剂中氨基的摩尔比为1:1~2:1加入。The amine crosslinking agent in the step (2) is any compound with two amino groups among ethylenediamine, lysine, and arginine, and the amount added is according to the The molar ratio of the aldehyde group to the amino group in the amine crosslinking agent is 1:1~2:1.
所述步骤(2)中的胺类交联剂为分子量为600g/mol~1800g/mol的树枝状聚乙烯亚胺(PEI)中的任一种带有两个以上氨基的化合物,加入量为按照部分醛基化葡聚糖中醛基与胺类交联剂中氨基的摩尔比为2:1~1:5加入。The amine crosslinking agent in the step (2) is any compound with two or more amino groups in the dendritic polyethyleneimine (PEI) with a molecular weight of 600g/mol~1800g/mol, and the addition amount is Add according to the molar ratio of the aldehyde group in the partially formylated dextran to the amino group in the amine crosslinking agent is 2:1~1:5.
所述步骤(3)中硼氢化钠与化学交联型葡聚糖水凝胶微球中C=N双键的摩尔比为2:1~10:1。In the step (3), the molar ratio of the sodium borohydride to the C=N double bonds in the chemically cross-linked dextran hydrogel microspheres is 2:1-10:1.
本发明基于葡聚糖的水凝胶微球的制备过程示意过程(以乙二胺作为交联剂为例)如下:The schematic diagram of the preparation process of the dextran-based hydrogel microspheres of the present invention (taking ethylenediamine as a cross-linking agent as an example) is as follows:
本发明的有益效果是:The beneficial effects of the present invention are:
1、本发明制得的葡聚糖基水凝胶微球是一种基于天然高分子材料的水凝胶微球,具有良好的生物安全性、稳定性和临床应用前景。1. The dextran-based hydrogel microspheres prepared in the present invention are hydrogel microspheres based on natural polymer materials, and have good biological safety, stability and clinical application prospects.
2、本发明涉及的葡聚糖基水凝胶微球通过反相微乳液交联法获得,通过调控反相微乳液的表面活性剂种类、构成及乳化方法可以对其形貌、粒径进行调控。2. The dextran-based hydrogel microspheres involved in the present invention are obtained by the reverse microemulsion cross-linking method, and their morphology and particle size can be adjusted by regulating the surfactant type, composition and emulsification method of the reverse microemulsion. regulation.
附图说明Description of drawings
图1是本发明实施例1还原前后的红外光谱图,其中a为还原前凝胶微球红外光谱图,b为还原后葡聚糖水凝胶微球的红外光谱图;Fig. 1 is the infrared spectrogram before and after reduction of Example 1 of the present invention, wherein a is the infrared spectrogram of gel microspheres before reduction, and b is the infrared spectrogram of dextran hydrogel microspheres after reduction;
图2是本发明实施例1还原前凝胶微球扫描电镜照片;Fig. 2 is the scanning electron micrograph of the gel microsphere before the reduction of Example 1 of the present invention;
图3是本发明实施例2还原前凝胶微球扫描电镜照片;3 is a scanning electron micrograph of the gel microspheres before reduction in Example 2 of the present invention;
图4是本发明实施例4还原前凝胶微球扫描电镜照片;Fig. 4 is the scanning electron micrograph of the gel microsphere before the reduction of Example 4 of the present invention;
图5是本发明实施例7还原前凝胶微球扫描电镜照片。Fig. 5 is a scanning electron micrograph of gel microspheres before reduction in Example 7 of the present invention.
具体实施方式Detailed ways
下面结合附图和具体实施方式,对本发明作进一步说明。The present invention will be further described below in combination with the accompanying drawings and specific embodiments.
实施例1Example 1
该基于葡聚糖的水凝胶微球,其结构式可表示如下:The structural formula of the dextran-based hydrogel microspheres can be expressed as follows:
。 .
该上述的基于葡聚糖的水凝胶微球的制备方法,其具体步骤包括如下:The preparation method of the above-mentioned dextran-based hydrogel microspheres, its specific steps include as follows:
(1)醛基化葡聚糖的制备(1) Preparation of aldylated dextran
将5.0g葡聚糖(葡聚糖T10,分子量为10000g/mol)在室温下按照固液比为10:100g/ml溶解在水中,然后置于冰水浴中按照糖单元/IO4 -摩尔比为1:1加入高碘酸钠获得混合液,将混合液在室温、避光条件下搅拌反应4h,获得的溶液用再生纤维素透析袋(截留分子量为5kD)在去离子水中透析2~3天,透析过程中每3~5h换一次去离子水,透析完成后冷冻干燥得到醛基化程度为60%的部分醛基化葡聚糖固体(即每100个糖单元中有60个被氧化);Dissolve 5.0g dextran (dextran T10, molecular weight 10000g/mol) in water at room temperature according to the solid-to-liquid ratio of 10:100g/ml, and then place it in an ice-water bath according to the molar ratio of sugar unit/ IO 4 Add sodium periodate at a ratio of 1:1 to obtain a mixed solution, stir the mixed solution at room temperature and under light-proof conditions for 4 hours, and dialyze the obtained solution in deionized water for 2 to 3 hours with a regenerated cellulose dialysis bag (molecular weight cut-off: 5kD). During the dialysis process, the deionized water was changed every 3~5h. After the dialysis was completed, freeze-dried to obtain a partially formylated dextran solid with a degree of formylation of 60% (that is, 60 out of every 100 sugar units were oxidized). );
(2)葡聚糖水凝胶微球的制备(2) Preparation of dextran hydrogel microspheres
将步骤(1)得到的0.15g部分醛基化葡聚糖固体溶于1.0mL去离子水中得到浓度为150mg/mL的醛基化葡聚糖水溶液,在室温下,将醛基化葡聚糖水溶液加入溶解了乳化剂的环己烷溶液中,剧烈搅拌15min乳化形成反相微乳液,然后加入胺类交联剂搅拌12h,最后通过离心(1500rpm,5min)收集沉淀物,沉淀物经乙醇清洗5~6次后得到化学交联型葡聚糖水凝胶微球,分散于2.0mL去离子水中保存,该化学交联型葡聚糖水凝胶微球通过真空干燥获得淡黄色固体粉末,其红外光谱如图1(a)所示;采用扫描电子显微镜对获得的凝胶微球的形貌进行了观察,结果如图2所示:该条件下获得的葡聚糖凝胶微球具有规整的球形结构,微球表面光滑,粒径分布在30~90μm之间;其中环己烷用量为8.0mL,醛基化葡聚糖水溶液与环己烷体积比为1:8,乳化剂为Span80,加入量为2.0g(乳化剂的加入量为环己烷溶液质量的32%),搅拌为机械搅拌;其中胺类交联剂为乙二胺,加入量为按照部分醛基化葡聚糖中醛基与胺类交联剂中氨基的摩尔比为2:1加入(约18μL);Dissolve 0.15 g of the partially formylated dextran solid obtained in step (1) in 1.0 mL of deionized water to obtain an aqueous solution of formylated dextran with a concentration of 150 mg/mL. Add the aqueous solution into the cyclohexane solution in which the emulsifier is dissolved, stir vigorously for 15 minutes to emulsify to form a reverse microemulsion, then add an amine cross-linking agent and stir for 12 hours, and finally collect the precipitate by centrifugation (1500rpm, 5min), and wash the precipitate with ethanol After 5-6 times, the chemically cross-linked dextran hydrogel microspheres were obtained, which were dispersed in 2.0 mL deionized water for storage. The chemically cross-linked dextran hydrogel microspheres were dried in a vacuum to obtain a light yellow solid powder. The spectrum is shown in Figure 1(a); the morphology of the obtained gel microspheres was observed with a scanning electron microscope, and the results are shown in Figure 2: the dextran gel microspheres obtained under this condition have regular Spherical structure, smooth microsphere surface, particle size distribution between 30-90μm; the amount of cyclohexane is 8.0mL, the volume ratio of aldylated dextran aqueous solution to cyclohexane is 1:8, and the emulsifier is Span80. The addition amount is 2.0g (the addition amount of the emulsifier is 32% of the mass of the cyclohexane solution), and the stirring is mechanical stirring; the amine cross-linking agent is ethylenediamine, and the addition amount is according to the partial formylated dextran The molar ratio of the aldehyde group to the amino group in the amine cross-linking agent is 2:1 and added (about 18 μL);
(3)葡聚糖水凝胶微球的还原(3) Reduction of dextran hydrogel microspheres
向步骤(2)得到分散于去离子水中的化学交联型葡聚糖水凝胶微球中加入50mg硼氢化钠(硼氢化钠与葡聚糖水凝胶微球中C=N双键的摩尔比约为2.5:1),在室温下搅拌24h,最后通过离心(1500rpm,5min)收集沉淀物,沉淀物经去离子水清洗5~6次后得到还原后的葡聚糖水凝胶微球,分散于2.0mL去离子水中保存。还原后的葡聚糖水凝胶微球通过真空干燥后获得白色固体粉末,其红外光谱如图1(b)所示。Add 50 mg of sodium borohydride to the chemically cross-linked dextran hydrogel microspheres dispersed in deionized water obtained in step (2) (the molar ratio of sodium borohydride to the C=N double bond in the dextran hydrogel microspheres About 2.5:1), stirred at room temperature for 24 hours, and finally collected the precipitate by centrifugation (1500rpm, 5min). Store in 2.0 mL deionized water. The reduced dextran hydrogel microspheres obtained a white solid powder after vacuum drying, and its infrared spectrum is shown in Figure 1(b).
实施例2Example 2
该基于葡聚糖的水凝胶微球,其结构式可表示如下:The structural formula of the dextran-based hydrogel microspheres can be expressed as follows:
。 .
该上述的基于葡聚糖的水凝胶微球的制备方法,其具体步骤包括如下:The preparation method of the above-mentioned dextran-based hydrogel microspheres, its specific steps include as follows:
(1)醛基化葡聚糖的制备(1) Preparation of aldylated dextran
将5.0g葡聚糖(葡聚糖T40,分子量为40000g/mol)在室温下按照固液比为10:100g/ml溶解在水中,然后置于冰水浴中按照糖单元/IO4 -摩尔比为1:1加入高碘酸钠获得混合液,将混合液在室温、避光条件下搅拌反应4h,获得的溶液用再生纤维素透析袋(截留分子量为7kD)在去离子水中透析2~3天,透析过程中每3~5h换一次去离子水,透析完成后冷冻干燥得到醛基化程度为60%的部分醛基化葡聚糖固体(即每100个糖单元中有60个被氧化);Dissolve 5.0g of dextran (dextran T40, molecular weight 40000g/mol) in water at room temperature according to the solid-to-liquid ratio of 10:100g/ml, and then place it in an ice-water bath according to the molar ratio of sugar unit/ IO 4 Add sodium periodate at a ratio of 1:1 to obtain a mixed solution, stir the mixed solution at room temperature and in the dark for 4 hours, and dialyze the obtained solution in deionized water for 2 to 3 hours with a regenerated cellulose dialysis bag (molecular weight cut-off: 7kD). During the dialysis process, the deionized water was changed every 3~5h. After the dialysis was completed, freeze-dried to obtain a partially formylated dextran solid with a degree of formylation of 60% (that is, 60 out of every 100 sugar units were oxidized). );
(2)葡聚糖水凝胶微球的制备(2) Preparation of dextran hydrogel microspheres
将步骤(1)得到的0.15g部分醛基化葡聚糖固体溶于1.0mL去离子水中得到浓度为150mg/mL的醛基化葡聚糖水溶液,在室温下,将醛基化葡聚糖水溶液加入溶解了乳化剂的环己烷溶液中,剧烈搅拌15min乳化形成反相微乳液,然后加入胺类交联剂搅拌12h,最后通过离心(3000rpm,5min)收集沉淀物,沉淀物经乙醇清洗5~6次后得到化学交联型葡聚糖水凝胶微球,分散于2.0ml去离子水中保存,采用扫描电子显微镜对获得的凝胶微球的形貌进行了观察,结果如图3所示:该条件下获得的葡聚糖凝胶微球具有规整的球形结构,微球表面光滑,粒径分布在10~50μm之间;其中环己烷用量为8.0mL,醛基化葡聚糖水溶液与环己烷体积比为1:8,乳化剂为Span80/Tween80的复配剂,加入量Span80为2.0g,Tween80为0.2g(乳化剂的加入量为环己烷质量的35%),搅拌为机械搅拌;其中胺类交联剂为乙二胺,加入量为按照部分醛基化葡聚糖中醛基与胺类交联剂中氨基的摩尔比为2:1加入(约18μL);Dissolve 0.15 g of the partially formylated dextran solid obtained in step (1) in 1.0 mL of deionized water to obtain an aqueous solution of formylated dextran with a concentration of 150 mg/mL. Add the aqueous solution into the cyclohexane solution dissolved in the emulsifier, stir vigorously for 15 minutes to emulsify to form a reverse microemulsion, then add an amine cross-linking agent and stir for 12 hours, and finally collect the precipitate by centrifugation (3000rpm, 5min), and wash the precipitate with ethanol After 5 to 6 times, the chemically cross-linked dextran hydrogel microspheres were obtained, which were dispersed in 2.0ml deionized water and stored. The morphology of the obtained gel microspheres was observed by scanning electron microscopy, and the results are shown in Figure 3 It shows that the dextran gel microspheres obtained under this condition have a regular spherical structure, the surface of the microspheres is smooth, and the particle size distribution is between 10 and 50 μm; the amount of cyclohexane is 8.0 mL, and the formaldehyde dextran The volume ratio of aqueous solution to cyclohexane is 1:8, the emulsifier is a compound of Span80/Tween80, the amount of Span80 added is 2.0g, and the amount of Tween80 is 0.2g (the amount of emulsifier added is 35% of the mass of cyclohexane), Stirring is mechanical stirring; the amine cross-linking agent is ethylenediamine, and the amount added is 2:1 according to the molar ratio of the aldehyde group in the partially formylated dextran to the amino group in the amine cross-linking agent (about 18 μL) ;
(3)葡聚糖水凝胶微球的还原(3) Reduction of dextran hydrogel microspheres
向步骤(2)得到分散于去离子水中的化学交联型葡聚糖水凝胶微球中加入50mg硼氢化钠(硼氢化钠与化学交联型葡聚糖水凝胶微球中C=N双键的摩尔比为2.5:1),在室温下搅拌24h,最后通过离心(3000rpm,5min)收集沉淀物,沉淀物经去离子水清洗5~6次后得到还原后的葡聚糖水凝胶微球,分散于2.0mL去离子水中保存。还原后的葡聚糖水凝胶微球分散于一系列不同pH的磷酸氢二钠-柠檬酸缓冲液中,对其稳定性进行了观察,结果如表1所示:在pH>4.0环境条件下,葡聚糖凝胶微球在水溶液中具有良好的稳定性,当溶液pH<4.0时,葡聚糖凝胶微球结构被破坏,稳定性较差。Add 50 mg of sodium borohydride to the chemically cross-linked dextran hydrogel microspheres dispersed in deionized water obtained in step (2) (C=N double in sodium borohydride and chemically cross-linked dextran hydrogel microspheres The molar ratio of bond is 2.5:1), stirred at room temperature for 24h, and finally collected the precipitate by centrifugation (3000rpm, 5min). Balls, dispersed in 2.0mL deionized water for storage. The reduced dextran hydrogel microspheres were dispersed in a series of disodium hydrogen phosphate-citric acid buffer solutions with different pHs, and their stability was observed. The results are shown in Table 1: under the environmental conditions of pH>4.0 , the dextran gel microspheres have good stability in aqueous solution, and when the solution pH<4.0, the structure of the dextran gel microspheres is destroyed and the stability is poor.
表1Table 1
实施例3Example 3
该基于葡聚糖的水凝胶微球,其结构式可表示如下:The structural formula of the dextran-based hydrogel microspheres can be expressed as follows:
。 .
该上述的基于葡聚糖的水凝胶微球的制备方法,其具体步骤包括如下:The preparation method of the above-mentioned dextran-based hydrogel microspheres, its specific steps include as follows:
(1)醛基化葡聚糖的制备(1) Preparation of aldylated dextran
将5.0g葡聚糖(葡聚糖T70,分子量为70000g/mol)在室温下按照固液比为10:100g/ml溶解在水中,然后置于冰水浴中按照糖单元/IO4 -摩尔比为1:1加入高碘酸钠获得混合液,将混合液在室温、避光条件下搅拌反应4h,将搅拌后的溶液用再生纤维素透析袋(截留分子量为7kD)在去离子水中透析2~3天,透析过程中每3~5h换一次去离子水,透析完成后冷冻干燥得到醛基化程度为60%的部分醛基化葡聚糖固体(即每100个糖单元中有60个被氧化);Dissolve 5.0g of dextran (dextran T70, molecular weight 70000g/mol) in water at room temperature according to the solid-to-liquid ratio of 10:100g/ml, and then place it in an ice-water bath according to the molar ratio of sugar unit/ IO 4 Add sodium periodate at a ratio of 1:1 to obtain a mixed solution, stir the mixed solution at room temperature and under light-proof conditions for 4 hours, and dialyze the stirred solution in deionized water for 2 For ~3 days, the deionized water was changed every 3~5h during the dialysis process. After the dialysis was completed, freeze-dried to obtain a partially aldylated dextran solid with a degree of aldylation of 60% (that is, there were 60 sugar units per 100 Oxidized);
(2)葡聚糖水凝胶微球的制备(2) Preparation of dextran hydrogel microspheres
将步骤(1)得到的0.1g部分醛基化葡聚糖固体溶于1.0mL去离子水中得到浓度为100mg/mL的醛基化葡聚糖水溶液,在室温下,将醛基化葡聚糖水溶液加入溶解了乳化剂的环己烷溶液中,剧烈搅拌15min乳化形成反相微乳液,然后加入胺类交联剂搅拌12h,最后通过离心(3000rpm,5min)收集沉淀物,沉淀物经乙醇清洗5~6次后得到化学交联型葡聚糖水凝胶微球,分散于2.0ml去离子水中保存;其中环己烷用量为8.0mL,醛基化葡聚糖水溶液与环己烷体积比为1:8,乳化剂为Span80/Tween80的复配剂,加入量Span80为2.0g,Tween80为0.4g(乳化剂的加入量为环己烷溶液质量的38%),搅拌为机械搅拌;其中胺类交联剂为乙二胺,加入量为按照部分醛基化葡聚糖中醛基与胺类交联剂中氨基的摩尔比为2:1加入(约12μL);Dissolve 0.1 g of the partially formylated dextran solid obtained in step (1) in 1.0 mL of deionized water to obtain an aqueous solution of formylated dextran with a concentration of 100 mg/mL. Add the aqueous solution into the cyclohexane solution dissolved in the emulsifier, stir vigorously for 15 minutes to emulsify to form a reverse microemulsion, then add an amine cross-linking agent and stir for 12 hours, and finally collect the precipitate by centrifugation (3000rpm, 5min), and wash the precipitate with ethanol After 5 to 6 times, the chemically cross-linked dextran hydrogel microspheres were obtained, which were dispersed in 2.0ml deionized water for storage; the amount of cyclohexane was 8.0mL, and the volume ratio of aldylated dextran aqueous solution to cyclohexane was 1:8, the emulsifier is a compound of Span80/Tween80, the amount of Span80 added is 2.0g, and the amount of Tween80 is 0.4g (the amount of emulsifier added is 38% of the mass of the cyclohexane solution), and the stirring is mechanical; the amine The cross-linking agent is ethylenediamine, and the amount added is 2:1 according to the molar ratio of the aldehyde group in the partially formylated dextran to the amino group in the amine cross-linking agent (about 12 μL);
(3)葡聚糖水凝胶微球的还原(3) Reduction of dextran hydrogel microspheres
向步骤(2)得到分散于去离子水中的化学交联型葡聚糖水凝胶微球中加入50mg硼氢化钠(硼氢化钠与化学交联型葡聚糖水凝胶微球中C=N双键的摩尔比约为4:1),在室温下搅拌24h,最后通过离心(3000rpm,5min)收集沉淀物,沉淀物经去离子水清洗5~6次后得到还原后的葡聚糖水凝胶微球,分散于2.0mL去离子水中保存。Add 50 mg of sodium borohydride to the chemically cross-linked dextran hydrogel microspheres dispersed in deionized water obtained in step (2) (C=N double in sodium borohydride and chemically cross-linked dextran hydrogel microspheres The molar ratio of the bond is about 4:1), stirred at room temperature for 24 hours, and finally collected the precipitate by centrifugation (3000rpm, 5min). The precipitate was washed with deionized water for 5-6 times to obtain the reduced dextran hydrogel Microspheres, dispersed in 2.0mL deionized water for storage.
实施例4Example 4
该基于葡聚糖的水凝胶微球,其结构式可表示如下:The structural formula of the dextran-based hydrogel microspheres can be expressed as follows:
。 .
该上述的基于葡聚糖的水凝胶微球的制备方法,其具体步骤包括如下:The preparation method of the above-mentioned dextran-based hydrogel microspheres, its specific steps include as follows:
(1)醛基化葡聚糖的制备(1) Preparation of aldylated dextran
将5.0g葡聚糖(葡聚糖T40,分子量为40000g/mol)在室温下按照固液比为10:100g/ml溶解在水中,然后置于冰水浴中按照糖单元/IO4 -摩尔比为1:1加入高碘酸钠获得混合液,将混合液在室温、避光条件下搅拌反应4h,获得的溶液用再生纤维素透析袋(截留分子量为7kD)在去离子水中透析2~3天,透析过程中每3~5h换一次去离子水,透析完成后冷冻干燥得到醛基化程度为60%的部分醛基化葡聚糖固体(即每100个糖单元中有60个被氧化);Dissolve 5.0g of dextran (dextran T40, molecular weight 40000g/mol) in water at room temperature according to the solid-to-liquid ratio of 10:100g/ml, and then place it in an ice-water bath according to the molar ratio of sugar unit/ IO 4 Add sodium periodate at a ratio of 1:1 to obtain a mixed solution, stir the mixed solution at room temperature and in the dark for 4 hours, and dialyze the obtained solution in deionized water for 2 to 3 hours with a regenerated cellulose dialysis bag (molecular weight cut-off: 7kD). During the dialysis process, the deionized water was changed every 3~5h. After the dialysis was completed, freeze-dried to obtain a partially formylated dextran solid with a degree of formylation of 60% (that is, 60 out of every 100 sugar units were oxidized). );
(2)葡聚糖水凝胶微球的制备(2) Preparation of dextran hydrogel microspheres
将步骤(1)得到的0.1g部分醛基化葡聚糖固体溶于1.0mL去离子水中得到浓度为100mg/mL的醛基化葡聚糖水溶液,在室温下,将醛基化葡聚糖水溶液加入溶解了乳化剂的环己烷溶液中,剧烈搅拌30min乳化形成反相微乳液,然后加入胺类交联剂搅拌12h,最后通过离心(4000rpm,5min)收集沉淀物,沉淀物经乙醇清洗5~6次后得到化学交联型葡聚糖水凝胶微球,分散于2.0ml去离子水中保存,采用扫描电子显微镜对获得的凝胶微球的形貌进行了观察,结果如图4所示:该条件下获得的葡聚糖凝胶微球具有规整的球形结构,微球表面光滑,粒径分布在2~6μm之间;其中环己烷用量为8.0mL,醛基化葡聚糖水溶液与环己烷体积比为1:8,乳化剂为CO-520,加入量为3.0g(乳化剂的加入量为环己烷质量的48%),搅拌为机械搅拌;其中胺类交联剂为乙二胺,加入量为按照部分醛基化葡聚糖中醛基与胺类交联剂中氨基的摩尔比为2:1加入(约12μL);Dissolve 0.1 g of the partially formylated dextran solid obtained in step (1) in 1.0 mL of deionized water to obtain an aqueous solution of formylated dextran with a concentration of 100 mg/mL. Add the aqueous solution into the cyclohexane solution dissolved in the emulsifier, stir vigorously for 30 minutes to emulsify to form a reverse microemulsion, then add an amine cross-linking agent and stir for 12 hours, and finally collect the precipitate by centrifugation (4000rpm, 5min), and wash the precipitate with ethanol After 5 to 6 times, the chemically cross-linked dextran hydrogel microspheres were obtained, which were dispersed in 2.0ml deionized water and stored. The morphology of the obtained gel microspheres was observed by scanning electron microscopy, and the results are shown in Figure 4 The results show that the dextran gel microspheres obtained under this condition have a regular spherical structure, the surface of the microspheres is smooth, and the particle size distribution is between 2 and 6 μm; the amount of cyclohexane is 8.0 mL, and the formaldehyde dextran The volume ratio of aqueous solution to cyclohexane is 1:8, the emulsifier is CO-520, the amount added is 3.0g (the amount of emulsifier added is 48% of the mass of cyclohexane), and the stirring is mechanical stirring; the amine crosslinking The agent is ethylenediamine, and the amount added is 2:1 according to the molar ratio of the aldehyde group in the partially formylated dextran to the amino group in the amine crosslinking agent (about 12 μL);
(3)葡聚糖水凝胶微球的还原(3) Reduction of dextran hydrogel microspheres
向步骤(2)得到分散于去离子水中的化学交联型葡聚糖水凝胶微球中加入40mg硼氢化钠(硼氢化钠与化学交联型葡聚糖水凝胶微球中C=N双键的摩尔比约为3:1),在室温下搅拌24h,最后通过离心(4000rpm,5min)收集沉淀物,沉淀物经去离子水清洗5~6次后得到还原后的葡聚糖水凝胶微球,分散于2.0mL去离子水中保存。Add 40 mg of sodium borohydride to the chemically cross-linked dextran hydrogel microspheres dispersed in deionized water obtained in step (2) (C=N double in sodium borohydride and chemically cross-linked dextran hydrogel microspheres The molar ratio of the bond is about 3:1), stirred at room temperature for 24 hours, and finally collected the precipitate by centrifugation (4000rpm, 5min). The precipitate was washed with deionized water for 5-6 times to obtain the reduced dextran hydrogel Microspheres, dispersed in 2.0mL deionized water for storage.
实施例5Example 5
该基于葡聚糖的水凝胶微球,其结构式可表示如下:The structural formula of the dextran-based hydrogel microspheres can be expressed as follows:
。 .
该上述的基于葡聚糖的水凝胶微球的制备方法,其具体步骤包括如下:The preparation method of the above-mentioned dextran-based hydrogel microspheres, its specific steps include as follows:
(1)醛基化葡聚糖的制备(1) Preparation of aldylated dextran
将5.0g葡聚糖(葡聚糖T40,分子量为40000g/mol)在室温下按照固液比为10:100g/ml溶解在水中,然后置于冰水浴中按照糖单元/IO4 -摩尔比为2:1加入高碘酸钠获得混合液,将混合液在室温、避光条件下搅拌反应6h,获得的溶液用再生纤维素透析袋(截留分子量为7kD)在去离子水中透析2~3天,透析过程中每3~5h换一次去离子水,透析完成后冷冻干燥得到醛基化程度为40%的部分醛基化葡聚糖固体(即每100个糖单元中有40个被氧化);Dissolve 5.0g of dextran (dextran T40, molecular weight 40000g/mol) in water at room temperature according to the solid-to-liquid ratio of 10:100g/ml, and then place it in an ice-water bath according to the molar ratio of sugar unit/ IO 4 Add sodium periodate at a ratio of 2:1 to obtain a mixed solution, stir the mixed solution at room temperature and in the dark for 6 hours, and dialyze the obtained solution in deionized water for 2-3 hours with a regenerated cellulose dialysis bag (molecular weight cut-off: 7kD During the dialysis process, the deionized water was changed every 3~5h. After the dialysis was completed, freeze-dried to obtain a partially formylated dextran solid with a degree of formylation of 40% (that is, 40 out of every 100 sugar units were oxidized). );
(2)葡聚糖水凝胶微球的制备(2) Preparation of dextran hydrogel microspheres
将步骤(1)得到的0.1g部分醛基化葡聚糖固体溶于1.0mL去离子水中得到浓度为100mg/mL的醛基化葡聚糖水溶液,在室温下,将醛基化葡聚糖水溶液加入溶解了乳化剂的环己烷溶液中,剧烈搅拌30min乳化形成反相微乳液,然后加入胺类交联剂搅拌12h,最后通过离心(3000rpm,5min)收集沉淀物,沉淀物经乙醇清洗5~6次后得到化学交联型葡聚糖水凝胶微球,分散于2.0ml去离子水中保存;其中环己烷用量为8.0mL,醛基化葡聚糖水溶液与环己烷的体积比为1:8,乳化剂为Span80/Tween80复配剂,加入量为Span80为2.0g,Tween80为0.2g(乳化剂的加入量为环己烷质量的35%),搅拌为机械搅拌;其中胺类交联剂为PEI(PEI分子量为600g/mol,其溶液浓度为0.25g/mL),加入量为按照部分醛基化葡聚糖中醛基与胺类交联剂中氨基的摩尔比为1:1加入(0.2mL);Dissolve 0.1 g of the partially formylated dextran solid obtained in step (1) in 1.0 mL of deionized water to obtain an aqueous solution of formylated dextran with a concentration of 100 mg/mL. Add the aqueous solution into the cyclohexane solution dissolved in the emulsifier, stir vigorously for 30 minutes to emulsify to form a reverse microemulsion, then add an amine cross-linking agent and stir for 12 hours, and finally collect the precipitate by centrifugation (3000rpm, 5min), and wash the precipitate with ethanol After 5 to 6 times, the chemically cross-linked dextran hydrogel microspheres were obtained, which were dispersed in 2.0ml deionized water and stored; the amount of cyclohexane was 8.0mL, and the volume ratio of the aldylated dextran aqueous solution to cyclohexane The emulsifier is 1:8, the emulsifier is Span80/Tween80 compound, the addition amount is 2.0g for Span80, and 0.2g for Tween80 (the addition amount of emulsifier is 35% of the mass of cyclohexane), and the stirring is mechanical stirring; The cross-linking agent is PEI (the molecular weight of PEI is 600g/mol, and its solution concentration is 0.25g/mL), and the amount added is according to the molar ratio of the aldehyde group in the partially formylated dextran to the amino group in the amine cross-linking agent. 1:1 addition (0.2mL);
(3)化学交联型葡聚糖水凝胶微球的还原(3) Reduction of chemically cross-linked dextran hydrogel microspheres
向步骤(2)得到分散于去离子水中的化学交联型葡聚糖水凝胶微球中加入40mg硼氢化钠(硼氢化钠与化学交联型葡聚糖水凝胶微球中C=N双键的摩尔比为2:1),在室温下搅拌24h,最后通过离心(3000rpm,5min)收集沉淀物,沉淀物经去离子水清洗5~6次后得到还原后的葡聚糖水凝胶微球,分散于2.0mL去离子水中保存。Add 40 mg of sodium borohydride to the chemically cross-linked dextran hydrogel microspheres dispersed in deionized water obtained in step (2) (C=N double in sodium borohydride and chemically cross-linked dextran hydrogel microspheres The molar ratio of bond is 2:1), stirred at room temperature for 24h, and finally collected the precipitate by centrifugation (3000rpm, 5min). Balls, dispersed in 2.0mL deionized water for storage.
实施例6Example 6
该基于葡聚糖的水凝胶微球,其结构式可表示如下:The structural formula of the dextran-based hydrogel microspheres can be expressed as follows:
。 .
该上述的基于葡聚糖的水凝胶微球的制备方法,其具体步骤包括如下:The preparation method of the above-mentioned dextran-based hydrogel microspheres, its specific steps include as follows:
(1)醛基化葡聚糖的制备(1) Preparation of aldylated dextran
将5.0g葡聚糖(葡聚糖T70,分子量为70000g/mol)在室温下按照固液比为10:100g/ml溶解在水中,然后置于冰水浴中按照糖单元/IO4 -摩尔比为2:1加入高碘酸钠获得混合液,将混合液在室温、避光条件下搅拌反应6h,获得的溶液用再生纤维素透析袋(截留分子量为7kD)在去离子水中透析2~3天,透析过程中每3~5h换一次去离子水,透析完成后冷冻干燥得到醛基化程度约为40%的部分醛基化葡聚糖固体(即每100个糖单元中有40个被氧化);Dissolve 5.0g of dextran (dextran T70, molecular weight 70000g/mol) in water at room temperature according to the solid-to-liquid ratio of 10:100g/ml, and then place it in an ice-water bath according to the molar ratio of sugar unit/ IO 4 Add sodium periodate at a ratio of 2:1 to obtain a mixed solution, stir the mixed solution at room temperature and in the dark for 6 hours, and dialyze the obtained solution in deionized water for 2-3 hours with a regenerated cellulose dialysis bag (molecular weight cut-off: 7kD During the dialysis process, the deionized water was changed every 3-5 hours. After the dialysis was completed, freeze-dried to obtain a partially aldylated dextran solid with a degree of aldylation of about 40% (that is, 40 sugar units per 100 sugar units were oxidation);
(2)葡聚糖水凝胶微球的制备(2) Preparation of dextran hydrogel microspheres
将步骤(1)得到的0.2g部分醛基化葡聚糖固体溶于1.0mL去离子水中得到浓度为200mg/mL的醛基化葡聚糖水溶液,在室温下,将醛基化葡聚糖水溶液加入溶解了乳化剂的环己烷溶液中,剧烈搅拌30min乳化形成反相微乳液,然后加入胺类交联剂搅拌10h,最后通过离心(1500rpm,5min)收集沉淀物,沉淀物经乙醇清洗5~6次后得到化学交联型葡聚糖水凝胶微球,分散于2.0ml去离子水中保存;其中环己烷用量为10.0mL,醛基化葡聚糖水溶液与环己烷体积比为1:10,乳化剂为Span80,乳化剂的加入量为环己烷质量的10%,搅拌为机械搅拌;其中胺类交联剂为PEI(PEI分子量为1800g/mol,其溶液浓度为0.5g/mL),加入量为按照部分醛基化葡聚糖中醛基与胺类交联剂中氨基的摩尔比为2:1加入(0.2mL);Dissolve 0.2 g of the partially formylated dextran solid obtained in step (1) in 1.0 mL of deionized water to obtain an aqueous solution of formylated dextran with a concentration of 200 mg/mL. Add the aqueous solution into the cyclohexane solution dissolved in the emulsifier, stir vigorously for 30 minutes to emulsify to form a reverse microemulsion, then add an amine cross-linking agent and stir for 10 hours, and finally collect the precipitate by centrifugation (1500rpm, 5min), and wash the precipitate with ethanol After 5 to 6 times, the chemically cross-linked dextran hydrogel microspheres were obtained, which were dispersed in 2.0ml deionized water for storage; the amount of cyclohexane was 10.0mL, and the volume ratio of aldylated dextran aqueous solution to cyclohexane was 1:10, the emulsifier is Span80, the amount of emulsifier added is 10% of the mass of cyclohexane, and the stirring is mechanical stirring; the amine crosslinking agent is PEI (the molecular weight of PEI is 1800g/mol, and its solution concentration is 0.5g /mL), the amount added is 2:1 according to the molar ratio of the aldehyde group in the partially formylated dextran to the amino group in the amine crosslinking agent (0.2mL);
(3)葡聚糖水凝胶微球的还原(3) Reduction of dextran hydrogel microspheres
向步骤(2)得到分散于去离子水中的化学交联型葡聚糖水凝胶微球中加入硼氢化钠(硼氢化钠与化学交联型葡聚糖水凝胶微球C=N双键的摩尔比为2:1),在室温下搅拌24h,最后通过离心(1500rpm,5min)收集沉淀物,沉淀物经去离子水清洗5~6次后得到还原后的葡聚糖水凝胶微球,分散于2.0mL去离子水中保存。Add sodium borohydride (sodium borohydride and chemically cross-linked dextran hydrogel microspheres C=N double bond to the chemically cross-linked dextran hydrogel microspheres dispersed in deionized water obtained in step (2) The molar ratio is 2:1), stirred at room temperature for 24h, and finally collected the precipitate by centrifugation (1500rpm, 5min). The precipitate was washed with deionized water for 5-6 times to obtain the reduced dextran hydrogel microspheres. Disperse in 2.0mL deionized water and save.
实施例7Example 7
该基于葡聚糖的水凝胶微球,其结构式可表示如下:The structural formula of the dextran-based hydrogel microspheres can be expressed as follows:
。 .
该上述的基于葡聚糖的水凝胶微球的制备方法,其具体步骤包括如下:The preparation method of the above-mentioned dextran-based hydrogel microspheres, its specific steps include as follows:
(1)醛基化葡聚糖的制备(1) Preparation of aldylated dextran
将5.0g葡聚糖(葡聚糖T40,分子量为40000g/mol)在室温下按照固液比为10:100g/ml溶解在水中,然后置于冰水浴中按照糖单元/IO4 -摩尔比为1:1加入高碘酸钠获得混合液,将混合液在室温、避光条件下搅拌反应4h,获得的溶液用再生纤维素透析袋(截留分子量为7kD)在去离子水中透析2~3天,透析过程中每3~5h换一次去离子水,透析完成后冷冻干燥得到醛基化程度为60%的部分醛基化葡聚糖固体(即每100个糖单元中有60个被氧化);Dissolve 5.0g of dextran (dextran T40, molecular weight 40000g/mol) in water at room temperature according to the solid-to-liquid ratio of 10:100g/ml, and then place it in an ice-water bath according to the molar ratio of sugar unit/ IO 4 Add sodium periodate at a ratio of 1:1 to obtain a mixed solution, stir the mixed solution for 4 hours at room temperature and in the dark, and dialyze the obtained solution in deionized water for 2-3 During the dialysis process, the deionized water was changed every 3~5h. After the dialysis was completed, freeze-dried to obtain a partially formylated dextran solid with a degree of formylation of 60% (that is, 60 out of 100 sugar units were oxidized). );
(2)葡聚糖水凝胶微球的制备(2) Preparation of dextran hydrogel microspheres
将步骤(1)得到的0.1g部分醛基化葡聚糖固体溶于1.0mL去离子水中得到浓度为100mg/mL的醛基化葡聚糖水溶液,在室温下,将醛基化葡聚糖水溶液加入溶解了乳化剂的环己烷溶液中,超声乳化形成反相微乳液,然后加入胺类交联剂搅拌12h,最后通过离心(5000rpm,5min)收集沉淀物,沉淀物经乙醇清洗5~6次后得到化学交联型葡聚糖水凝胶微球,分散于2.0ml去离子水中保存;采用扫描电子显微镜对获得的凝胶微球的形貌进行了观察,结果如图5所示:该条件下获得的葡聚糖凝胶微球具有规整的球形结构,粒径分布在200~500nm之间;其中环己烷用量为8.0mL,醛基化葡聚糖水溶液与环己烷体积比为1:8,乳化剂为Span80/Tween80复配剂,加入量为Span80为2.0g,Tween80为0.2g(乳化剂的加入量为环己烷溶液质量的35%),超声乳化条件为:功率130W,振幅75%;胺类交联剂为乙二胺,加入量为按照部分醛基化葡聚糖中醛基与胺类交联剂中氨基的摩尔比为2:1加入(约12μL);Dissolve 0.1 g of the partially formylated dextran solid obtained in step (1) in 1.0 mL of deionized water to obtain an aqueous solution of formylated dextran with a concentration of 100 mg/mL. The aqueous solution is added to the cyclohexane solution in which the emulsifier is dissolved, ultrasonically emulsified to form an inverse microemulsion, then an amine crosslinking agent is added and stirred for 12 hours, and finally the precipitate is collected by centrifugation (5000rpm, 5min), and the precipitate is washed with ethanol for 5~ After 6 times, the chemically cross-linked dextran hydrogel microspheres were obtained, which were dispersed in 2.0ml deionized water and preserved; the morphology of the obtained gel microspheres was observed by scanning electron microscopy, and the results are shown in Figure 5: The dextran gel microspheres obtained under this condition have a regular spherical structure, and the particle size distribution is between 200 and 500nm; the amount of cyclohexane is 8.0mL, and the volume ratio of aldylated dextran aqueous solution to cyclohexane The ratio is 1:8, the emulsifier is Span80/Tween80 compound, the amount added is 2.0g for Span80, and 0.2g for Tween80 (the amount of emulsifier added is 35% of the mass of the cyclohexane solution), and the ultrasonic emulsification condition is: power 130W, amplitude 75%; the amine cross-linking agent is ethylenediamine, the amount added is 2:1 according to the molar ratio of the aldehyde group in the partially formylated dextran to the amino group in the amine cross-linking agent (about 12 μL) ;
(3)葡聚糖水凝胶微球的还原(3) Reduction of dextran hydrogel microspheres
向步骤(2)得到分散于去离子水中的化学交联型葡聚糖水凝胶微球中加入50mg硼氢化钠(硼氢化钠与化学交联型葡聚糖水凝胶微球中C=N双键的摩尔比约为4:1),在室温下搅拌24h,最后通过离心(5000rpm,5min)收集沉淀物,沉淀物经去离子水清洗5~6次后得到还原后的葡聚糖水凝胶微球,分散于2.0mL去离子水中保存。Add 50 mg of sodium borohydride to the chemically cross-linked dextran hydrogel microspheres dispersed in deionized water obtained in step (2) (C=N double in sodium borohydride and chemically cross-linked dextran hydrogel microspheres The molar ratio of the bond is about 4:1), stirred at room temperature for 24h, and finally collected the precipitate by centrifugation (5000rpm, 5min). The precipitate was washed with deionized water for 5-6 times to obtain the reduced dextran hydrogel Microspheres, dispersed in 2.0mL deionized water for storage.
实施例8Example 8
该基于葡聚糖的水凝胶微球,其结构式可表示如下:The structural formula of the dextran-based hydrogel microspheres can be expressed as follows:
。 .
该上述的基于葡聚糖的水凝胶微球的制备方法,其具体步骤包括如下:The preparation method of the above-mentioned dextran-based hydrogel microspheres, its specific steps include as follows:
(1)醛基化葡聚糖的制备(1) Preparation of aldylated dextran
将5.0g葡聚糖(葡聚糖T40,分子量为40000g/mol)在室温下按照固液比为10:100g/ml溶解在水中,然后置于冰水浴中按照糖单元/IO4 -摩尔比为1:1加入高碘酸钠获得混合液,将混合液在室温、避光条件下搅拌反应4h,获得的溶液用再生纤维素透析袋(截留分子量为7kD)在去离子水中透析2~3天,透析过程中每3~5h换一次去离子水,透析完成后冷冻干燥得到醛基化程度为60%的部分醛基化葡聚糖固体(即每100个糖单元中有60个被氧化);Dissolve 5.0g of dextran (dextran T40, molecular weight 40000g/mol) in water at room temperature according to the solid-to-liquid ratio of 10:100g/ml, and then place it in an ice-water bath according to the molar ratio of sugar unit/ IO 4 Add sodium periodate at a ratio of 1:1 to obtain a mixed solution, stir the mixed solution at room temperature and in the dark for 4 hours, and dialyze the obtained solution in deionized water for 2 to 3 hours with a regenerated cellulose dialysis bag (molecular weight cut-off: 7kD). During the dialysis process, the deionized water was changed every 3~5h. After the dialysis was completed, freeze-dried to obtain a partially formylated dextran solid with a degree of formylation of 60% (that is, 60 out of every 100 sugar units were oxidized). );
(2)葡聚糖水凝胶微球的制备(2) Preparation of dextran hydrogel microspheres
将步骤(1)得到的0.1g部分醛基化葡聚糖固体溶于1.0mL去离子水中得到浓度为100mg/mL的醛基化葡聚糖水溶液,在室温下,将醛基化葡聚糖水溶液加入溶解了乳化剂的环己烷溶液中,超声乳化形成反相微乳液,然后加入胺类交联剂搅拌12h,最后通过离心(5000rpm,5min)收集沉淀物,沉淀物经乙醇清洗5~6次后得到化学交联型葡聚糖水凝胶微球,分散于2.0ml去离子水中保存;采用扫描电子显微镜对获得的凝胶微球的形貌进行了观察,结果如图5所示:该条件下获得的葡聚糖凝胶微球具有规整的球形结构,粒径分布在200~500nm之间;其中环己烷用量为8.0mL,醛基化葡聚糖水溶液与环己烷体积比为1:8,乳化剂为Span80/Tween80复配剂,加入量为Span80为2.0g,Tween80为0.2g(乳化剂的加入量为环己烷溶液质量的35%),超声乳化条件为:功率130W,振幅75%;其中胺类交联剂为PEI(PEI分子量为600g/mol,其溶液浓度为0.5g/mL),加入量为按照部分醛基化葡聚糖中醛基与胺类交联剂中氨基的摩尔比为1:5加入;Dissolve 0.1 g of the partially formylated dextran solid obtained in step (1) in 1.0 mL of deionized water to obtain an aqueous solution of formylated dextran with a concentration of 100 mg/mL. The aqueous solution is added to the cyclohexane solution in which the emulsifier is dissolved, ultrasonically emulsified to form an inverse microemulsion, then an amine crosslinking agent is added and stirred for 12 hours, and finally the precipitate is collected by centrifugation (5000rpm, 5min), and the precipitate is washed with ethanol for 5~ After 6 times, the chemically cross-linked dextran hydrogel microspheres were obtained, which were dispersed in 2.0ml deionized water and preserved; the morphology of the obtained gel microspheres was observed by scanning electron microscopy, and the results are shown in Figure 5: The dextran gel microspheres obtained under this condition have a regular spherical structure, and the particle size distribution is between 200 and 500nm; the amount of cyclohexane is 8.0mL, and the volume ratio of aldylated dextran aqueous solution to cyclohexane The ratio is 1:8, the emulsifier is Span80/Tween80 compound, the amount added is 2.0g for Span80, and 0.2g for Tween80 (the amount of emulsifier added is 35% of the mass of the cyclohexane solution), and the ultrasonic emulsification condition is: power 130W, amplitude 75%; the amine cross-linking agent is PEI (the molecular weight of PEI is 600g/mol, and its solution concentration is 0.5g/mL), and the amount added is based on the cross-linking of aldehyde groups and amines in partially formylated dextran. The molar ratio of the amino group in the joint agent is added at 1:5;
(3)葡聚糖水凝胶微球的还原(3) Reduction of dextran hydrogel microspheres
向步骤(2)得到分散于去离子水中的化学交联型葡聚糖水凝胶微球中加入50mg硼氢化钠(硼氢化钠与化学交联型葡聚糖水凝胶微球中C=N双键的摩尔比约为10:1),在室温下搅拌24h,最后通过离心(5000rpm,5min)收集沉淀物,沉淀物经去离子水清洗5~6次后得到还原后的葡聚糖水凝胶微球,分散于2.0mL去离子水中保存。Add 50 mg of sodium borohydride to the chemically cross-linked dextran hydrogel microspheres dispersed in deionized water obtained in step (2) (C=N double in sodium borohydride and chemically cross-linked dextran hydrogel microspheres The molar ratio of the bond is about 10:1), stirred at room temperature for 24h, and finally collected the precipitate by centrifugation (5000rpm, 5min). The precipitate was washed with deionized water for 5-6 times to obtain the reduced dextran hydrogel Microspheres, dispersed in 2.0mL deionized water for storage.
以上结合附图对本发明的具体实施方式作了详细说明,但是本发明并不限于上述实施方式,在本领域普通技术人员所具备的知识范围内,还可以在不脱离本发明宗旨的前提下作出各种变化。The specific embodiments of the present invention have been described in detail above in conjunction with the accompanying drawings, but the present invention is not limited to the above embodiments. Variations.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510704378.4A CN105348548B (en) | 2015-10-27 | 2015-10-27 | A kind of hydrogel microsphere based on glucan and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510704378.4A CN105348548B (en) | 2015-10-27 | 2015-10-27 | A kind of hydrogel microsphere based on glucan and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105348548A CN105348548A (en) | 2016-02-24 |
CN105348548B true CN105348548B (en) | 2018-04-06 |
Family
ID=55324622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510704378.4A Expired - Fee Related CN105348548B (en) | 2015-10-27 | 2015-10-27 | A kind of hydrogel microsphere based on glucan and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105348548B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105949343B (en) * | 2016-05-04 | 2018-02-13 | 成都爱兴生物科技有限公司 | A kind of preparation method of the synthetic method of aldehydedodextrans, the method for coating based on the aldehydedodextrans and microsphere composition |
CN106729772B (en) * | 2017-01-05 | 2021-06-18 | 昆明理工大学 | Magnetic resonance contrast agent based on magnetic dextran hydrogel microspheres and preparation method thereof |
CN107252501A (en) * | 2017-04-13 | 2017-10-17 | 广州贝奥吉因生物科技有限公司 | A kind of composite aquogel support for loading sanguinarine/gelatine microsphere and its preparation method and application |
CN108732296B (en) * | 2017-04-14 | 2020-12-04 | 常州药物研究所有限公司 | Detection method of cross-linking degree of cross-linked dextran microspheres |
CN111388741B (en) * | 2020-04-01 | 2021-09-07 | 东华大学 | Injectable self-healing antibacterial hydrogel dressing with preloaded polypeptide and preparation method thereof |
CN112353781B (en) * | 2020-11-12 | 2022-08-19 | 云南开放大学 | Preparation method of hollow nanosphere of drug carrier |
CN113827554B (en) * | 2021-10-22 | 2024-01-23 | 西安交通大学 | Preparation method and application of aqueous gel |
CN113912871B (en) * | 2021-12-13 | 2022-04-15 | 浙江湃肽生物有限公司深圳分公司 | Separation method of palmitoyl pentapeptide-4 |
CN115850726B (en) * | 2022-12-12 | 2024-11-26 | 天津大学 | A biomedical grade conductive polymer aqueous dispersion, hydrogel and preparation method thereof |
CN116832213B (en) * | 2023-07-11 | 2024-07-30 | 杭州帕莱拉医疗科技有限公司 | Preparation method of injectable dextran/poly-L-lactic acid interpenetrating network microsphere composite hydrogel filler |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041292A (en) * | 1988-08-31 | 1991-08-20 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
CN101095964A (en) * | 2006-06-26 | 2008-01-02 | 房新雨 | Method for preparing glucosan gel rubber embolism microsphere suspending liquid |
CN101254307A (en) * | 2008-04-01 | 2008-09-03 | 江南大学 | A drug-loaded microsphere of hydrophobic drug and preparation method thereof |
CN102258787A (en) * | 2011-06-01 | 2011-11-30 | 天津大学 | Hydrophilic porous dextran-based microsphere and preparation method thereof |
-
2015
- 2015-10-27 CN CN201510704378.4A patent/CN105348548B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041292A (en) * | 1988-08-31 | 1991-08-20 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
CN101095964A (en) * | 2006-06-26 | 2008-01-02 | 房新雨 | Method for preparing glucosan gel rubber embolism microsphere suspending liquid |
CN101254307A (en) * | 2008-04-01 | 2008-09-03 | 江南大学 | A drug-loaded microsphere of hydrophobic drug and preparation method thereof |
CN102258787A (en) * | 2011-06-01 | 2011-11-30 | 天津大学 | Hydrophilic porous dextran-based microsphere and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
"Injectable bioadhesive hydrogels with innate antibacterial properties";Michael C. Giano 等;《NATURE COMMUNICATIONS》;20140624;第1-9页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105348548A (en) | 2016-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105348548B (en) | A kind of hydrogel microsphere based on glucan and preparation method thereof | |
Luque-Alcaraz et al. | Preparation of chitosan nanoparticles by nanoprecipitation and their ability as a drug nanocarrier | |
Kang et al. | Cellulose‐based gels | |
CN105111512B (en) | A kind of chemical crosslinking type dextran hydrogel and preparation method thereof | |
Masalova et al. | Alginate and chitosan gel nanoparticles for efficient protein entrapment | |
CN103304733B (en) | A kind of preparation method and application of degradable environment-responsive polymer nano hydrogel | |
CN102138904B (en) | Self-solidified microspheres and preparation method and application thereof | |
CN107652451B (en) | Silver nanoparticle hybrid supramolecular hydrogel based on cyclodextrin/PEG grafted polyacrylic acid, and preparation and application thereof | |
CN102921013A (en) | Preparation method and application of chitosan nanoparticles with pore structures | |
CN109081927B (en) | A kind of preparation method of hydrogel | |
CN104624129B (en) | Preparation method based on Ionic Liquid as Surface Active Agent microemulsion system starch nano-microsphere | |
Shi et al. | Preparation and sustainable release of modified konjac glucomannan/chitosan nanospheres | |
WO2020011240A1 (en) | Preparation method for double-sensitivity cellulose-based aerogel | |
CN108084460A (en) | A kind of cellulose/black phosphorus quantum dot composite hydrogel and preparation method thereof | |
CN106188574B (en) | A kind of carboxymethyl curdlan aqueous solution or hydrogel and its preparation method and application | |
Goycoolea et al. | Physical properties and stability of soft gelled chitosan‐based nanoparticles | |
CN103642190A (en) | Polyethylene glycol modified cyclodextrin, as well as preparation and application thereof | |
Li et al. | Cellulose gels and microgels: Synthesis, service, and supramolecular interactions | |
Manuel Laza | Covalently and ionically crosslinked chitosan nanogels for drug delivery | |
CN101612128A (en) | Alginic acid inorganic nanocomposite gel microspheres and preparation method thereof | |
Gupta et al. | Optimization of process variables for the preparation of chitosan-alginate nanoparticles | |
CN108201636A (en) | A kind of preparation method of the controllable natural polymer subbase 3D porous compound support frames in aperture | |
CN106832342A (en) | A kind of preparation method of the aldehyde hydrazine cross-linking type injectable PNIPAM hydrogels of nano-starch particle reinforcement | |
CN101608029B (en) | Polysaccharide nanoparticle composite supramolecular hydrogel and its preparation method | |
CN105838013B (en) | One kind is based on methyl vinyl ether maleic acid copolymer and the sensitive composite Nano gels of chitosan pH and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180406 |
|
CF01 | Termination of patent right due to non-payment of annual fee |